Alveolar epithelial type II cell: defender of the alveolus revisited
AUTOR(ES)
Fehrenbach, Heinz
FONTE
BioMed Central
RESUMO
In 1977, Mason and Williams developed the concept of the alveolar epithelial type II (AE2) cell as a defender of the alveolus. It is well known that AE2 cells synthesise, secrete, and recycle all components of the surfactant that regulates alveolar surface tension in mammalian lungs. AE2 cells influence extracellular surfactant transformation by regulating, for example, pH and [Ca2+] of the hypophase. AE2 cells play various roles in alveolar fluid balance, coagulation/fibrinolysis, and host defence. AE2 cells proliferate, differentiate into AE1 cells, and remove apoptotic AE2 cells by phagocytosis, thus contributing to epithelial repair. AE2 cells may act as immunoregulatory cells. AE2 cells interact with resident and mobile cells, either directly by membrane contact or indirectly via cytokines/growth factors and their receptors, thus representing an integrative unit within the alveolus. Although most data support the concept, the controversy about the character of hyperplastic AE2 cells, reported to synthesise profibrotic factors, proscribes drawing a definite conclusion today.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=59567Documentos Relacionados
- Fibronectin mediates adherence of rat alveolar type II epithelial cells via the fibroblastic cell-attachment domain.
- Potassium currents in rat type II alveolar epithelial cells.
- Phospholipid profile of Pneumocystis carinii and its interaction with alveolar type II epithelial cells.
- Pulmonary Alveolar Macrophage DEFENDER AGAINST BACTERIAL INFECTION OF THE LUNG
- Pulmonary alveolar type II epithelial cells synthesize and secrete proteins of the classical and alternative complement pathways.